XENOTHERA
A Xenotherapy platform with embedded technology that renovates immunological treatments
France
25 employees
Series C
Total: $26.51M
Biotechnology, Health and Wellness
General Information
France
BounceWatch is an independent company data service, not affiliated with XENOTHERA. To contact XENOTHERA, visit xenothera.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
France Market
Biotechnology
About XENOTHERA
Taxonomy: Xenotherapy, Immunological Treatments, Therapeutic Modes, Immunomodulation, Infectious Diseases, Passive Immunotherapy, Hyperimmune Polyclonal Sera, Animal Genetics, Immunology Processes, Market Authorization, Accelerated Development, Immunoglobulins, Immunogen, Business Focus
Services & Products
Target Customers
Funding Rounds & Investors (6)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series C | €17.84M | 5 |
|
29 Jun 2021 |
| Grant | €2.16M | 2 |
|
29 Jun 2021 |
| Grant | €2.30M | 1 |
|
01 Jul 2020 |
| Grant | €2.16M | 1 |
|
20 Mar 2020 |
| Grant | €50.00K | 1 |
EASME - EU Executive Agency for SMEs
|
01 Dec 2016 |
| Seed Round | €2.00M | 4 |
-logo.png){kind=logo}
|
30 Jun 2016 |
XENOTHERA Alternatives & Competitors
View All Alternatives
We bring better biologics to life. Biospace Best Place to Work 2024!
Pioneering groundbreaking therapies for cancer and immunological diseases with innovative antibody t...
Next generation antibody drug conjugates
FAQ About XENOTHERA
Source: BounceWatch company record for XENOTHERA, https://bouncewatch.com/company/xenothera, updated 7 June 2025. When citing, please name BounceWatch and link this page.
